Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen 2100, Denmark.
Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen 2100, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen 2200, Denmark.
Contemp Clin Trials. 2024 Jul;142:107548. doi: 10.1016/j.cct.2024.107548. Epub 2024 Apr 26.
Pulmonary hypertension is a progressive disease for which early treatment interventions are essential. Traditionally, patients undergo periodic clinical assessments. However, recent advances in wearable technology could improve the quality and efficiency of follow-up monitoring in patients with pulmonary hypertension.
To our knowledge, this is the first study describing direct data transmission from a smartwatch to patients' electronic health records. It implements a novel update and customised program to continuously and automatically transmit data from a smartwatch to the patient's electronic healthcare records. It will evaluate continuous monitoring in patients with pulmonary hypertension and monitor their physical activity time, heart rate variability, and heart rate at rest and during physical activity via a smartwatch. It will also evaluate the data transmission method, and its data will be assessed by the treating physicians supplemental to clinical practice. Smartwatch integration promises numerous advantages: comprehensive cardiovascular monitoring and improved patient experience. Our continuous smartwatch monitoring approach offers a solution for earlier detection of clinical worsening and could be included as a combined endpoint in future clinical trials. It could improve patient empowerment, enhance precision medicine, and reduce hospitalisations. The user-friendly smartwatch is designed to minimise disruption in daily life.
The ability to transfer real-time data from wearable devices to electronic health records could help to transform the treatment of patients with pulmonary hypertension and their follow-up monitoring outside a clinical setting, enhancing the efficiency of healthcare delivery.
肺动脉高压是一种进行性疾病，早期治疗干预至关重要。传统上，患者需要进行定期的临床评估。然而，可穿戴技术的最新进展可以提高肺动脉高压患者随访监测的质量和效率。
据我们所知，这是第一项描述智能手表与患者电子健康记录直接数据传输的研究。它实施了一种新颖的更新和定制程序，以持续自动地将数据从智能手表传输到患者的电子医疗记录中。它将评估肺动脉高压患者的连续监测，并通过智能手表监测他们的体力活动时间、心率变异性、静息和活动时的心率。它还将评估数据传输方法，其数据将由主治医生在临床实践之外进行评估。智能手表的集成具有许多优势：全面的心血管监测和改善患者体验。我们的连续智能手表监测方法为更早地发现临床恶化提供了一种解决方案，并可作为未来临床试验中的联合终点。它可以增强患者的自主权，提高精准医疗水平，并减少住院治疗。这款用户友好的智能手表旨在将日常生活中的干扰降到最低。
从可穿戴设备实时传输数据到电子健康记录的能力，可以帮助改变肺动脉高压患者的治疗和其在临床环境之外的随访监测，提高医疗保健的效率。
